Orthopediatrics Corp (NASDAQ:KIDS) shares shot up 5.4% on Monday . The company traded as high as $45.00 and last traded at $44.85. Approximately 120,207 shares traded hands during mid-day trading, a decline of 13% from the average session volume of 137,956 shares. The stock had previously closed at $42.57.
A number of research firms recently weighed in on KIDS. BTIG Research upped their price target on Orthopediatrics from $48.00 to $54.00 and gave the stock a “buy” rating in a report on Monday, June 8th. BidaskClub lowered shares of Orthopediatrics from a “buy” rating to a “hold” rating in a report on Wednesday, September 2nd. Zacks Investment Research cut shares of Orthopediatrics from a “hold” rating to a “sell” rating in a research note on Thursday, August 13th. Stifel Nicolaus raised their price target on shares of Orthopediatrics from $48.00 to $55.00 in a research note on Tuesday, June 16th. Finally, Needham & Company LLC increased their target price on Orthopediatrics from $49.00 to $57.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $52.29.
The stock has a market cap of $883.81 million, a PE ratio of -33.04 and a beta of 0.72. The stock’s fifty day moving average is $48.68 and its 200-day moving average is $44.79. The company has a debt-to-equity ratio of 0.09, a current ratio of 7.28 and a quick ratio of 5.31.
In other news, CEO Mark C. Throdahl sold 13,389 shares of Orthopediatrics stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $42.88, for a total transaction of $574,120.32. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 33.60% of the stock is owned by company insiders.
Several institutional investors and hedge funds have recently made changes to their positions in KIDS. Ameritas Investment Partners Inc. lifted its holdings in shares of Orthopediatrics by 31.7% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 1,056 shares of the company’s stock worth $46,000 after acquiring an additional 254 shares during the last quarter. Great West Life Assurance Co. Can increased its holdings in Orthopediatrics by 216.1% in the 2nd quarter. Great West Life Assurance Co. Can now owns 1,078 shares of the company’s stock valued at $47,000 after purchasing an additional 737 shares during the last quarter. Parkside Financial Bank & Trust raised its position in Orthopediatrics by 45.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,481 shares of the company’s stock valued at $65,000 after purchasing an additional 464 shares during the period. BNP Paribas Arbitrage SA lifted its stake in Orthopediatrics by 133.4% during the first quarter. BNP Paribas Arbitrage SA now owns 3,050 shares of the company’s stock worth $121,000 after purchasing an additional 1,743 shares in the last quarter. Finally, Captrust Financial Advisors acquired a new stake in shares of Orthopediatrics in the second quarter valued at $136,000. Institutional investors and hedge funds own 67.30% of the company’s stock.
About Orthopediatrics (NASDAQ:KIDS)
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
Read More: What does RSI mean?
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.